Trials / Completed
CompletedNCT02749578
Drug Interaction Study of MGL-3196 With Atorvastatin
A Single Center, Open-label, Drug Interaction Study of MGL-3196 With Atorvastatin in Healthy Subjects
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 14 (actual)
- Sponsor
- Madrigal Pharmaceuticals, Inc. · Industry
- Sex
- All
- Age
- 18 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to determine whether MGL-3196 alters the pharmacokinetics of atorvastatin in healthy male subjects and female subjects not of child-bearing potential.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Atorvastatin | |
| DRUG | MGL-3196 |
Timeline
- Start date
- 2016-04-01
- Primary completion
- 2016-05-01
- Completion
- 2016-05-01
- First posted
- 2016-04-25
- Last updated
- 2016-08-30
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02749578. Inclusion in this directory is not an endorsement.